Literature DB >> 32588321

Viral Hepatitides, Inflammation and Tumour Microenvironment.

Eleonora Timperi1,2, Vincenzo Barnaba3,4,5.   

Abstract

In this chapter, we discuss the role of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in the establishment of hepatocellular carcinoma (HCC), highlighting the key role of the multiple, non-mutually exclusive, pathways involved in the modulation of immune responses and in the orchestration of a chronic low-level inflammation state favouring HCC development. In particular, we discuss (i) HCC as a classical paradigm of inflammation-linked cancer; (ii) the role of the most relevant inflammatory cytokines involved (i.e. IL-6, TNF-α, IL-18, IL-1β, TGF-β IL-10); (iii) the role of T cell exhaustion by immune checkpoints; (iv) the role of the Wnt3a/β-catenin signalling pathway and (v) the role of different subsets of suppressor cells.

Entities:  

Keywords:  Chronic low-level inflammation; Cytokines; HBV; HCV; Hepatic sentinel cells; Hepatocellular carcinoma; Immune checkpoint blockade; Immunopathology; Immunoregulatory mechanisms; Liver; Suppressor cells; T cell exhaustion; T cells; Tumour microenvironment; Wnt/β-catenin

Mesh:

Year:  2020        PMID: 32588321     DOI: 10.1007/978-3-030-44518-8_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

Review 2.  Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.

Authors:  Min Yao; Jun-Ling Yang; De-Feng Wang; Li Wang; Ying Chen; Deng-Fu Yao
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

3.  Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma.

Authors:  Wei Hu; Dongsheng Liu; Renjie Li; Hong Qian; Wei Qiu; Qingwang Ye; Fanyun Kong
Journal:  Front Genet       Date:  2022-07-07       Impact factor: 4.772

Review 4.  Advances and challenges of immunocheckpoint inhibitors in the treatment of primary liver cancer.

Authors:  Meng Hu; Weirong Yao; Qinglin Shen
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

5.  Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis.

Authors:  Natalia I Krupenko; Jaspreet Sharma; Halle M Fogle; Peter Pediaditakis; Kyle C Strickland; Xiuxia Du; Kristi L Helke; Susan Sumner; Sergey A Krupenko
Journal:  Cancers (Basel)       Date:  2021-06-28       Impact factor: 6.575

Review 6.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

Review 7.  T Cell Memory in Infection, Cancer, and Autoimmunity.

Authors:  Vincenzo Barnaba
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.